Contributor: AI-Based Remote Monitoring for Age-Related Macular Degeneration: Promise, Progress, and Pitfalls
Neovascular age‑related macular degeneration (nAMD) affects roughly 1.5 million Americans and drives over $4 billion in Medicare anti‑VEGF spending. The FDA‑cleared Notal Vision home OCT (hOCT) offers daily AI‑driven retinal scans that could extend injection intervals, but a new cost model shows it is only cost‑saving for patients with high injection frequencies using expensive agents. For cheaper drugs or low‑burden patients, device fees and physician review time make hOCT more expensive than traditional clinic monitoring. Ongoing outcome trials will determine whether clinical benefits justify the higher costs.
An Implantable Living Pharmacy Produces Drugs in the Body
Scientists from Northwestern, Rice, and Carnegie Mellon unveiled a sub‑cutaneous implant called HOBIT that can synthesize multiple biologic drugs inside the body. The device houses engineered cells in an alginate hydrogel and an electrocatalytic oxygenator that supplies oxygen, enabling sustained...
Health Care Startups Desperately Need Clinical Expertise
Health‑care venture capital continues to pour money into startups designed by technologists rather than clinicians, creating products that clash with established workflows. Dr. Harsha Moole argues that physician‑scientists bring a structural advantage by vetting opportunities through three gates—clinical necessity, regulatory feasibility,...
The Perioperative AI Reality Check: Why Hospital Tech Fails Without Clinician Co-Design
Hospital leaders are rushing AI‑powered perioperative tools without clinician input, leading to low adoption and wasted spend. Andrew Fisher, MD, argues that the technology already exists, but success hinges on automating non‑clinical tasks, seamless workflow integration, and co‑design with anesthesiologists,...
Workday Launches COVID-19 Vaccine Management Solution to Enable Organizations
Workday announced a new vaccine‑management solution that integrates real‑time HR data with immunization records for its 45 million‑worker customer base. The offering adds dashboards that show vaccination rates, status by location and role, and supports scenario planning for office space, PPE...
Personalized CRISPR Fixes Baby KJ’s Genetic Defect
In just 6 months a team at @ChildrensPhila & @PennMedicine designed a personalized CRISPR based Rx to correct the single misspelled letter in Baby KJ’s DNA that results in CPS1 deficiency. Recent advances in mRNA science & CRISPR gene...
AI-Powered EMS Guides Users Through Unfamiliar Tasks
A new AI-driven system uses context-aware electrical muscle stimulation to physically guide users through unfamiliar tasks, merging computer vision and real-time reasoning to deliver tailored, on-the-spot movement assistance. embodiedai
TEFCA Can Enable Patient-Centered Data Exchange
University of Iowa Health Care’s Josh Wilda highlighted that the Trusted Exchange Framework and Common Agreement (TEFCA) could go beyond provider‑to‑provider connectivity to unify the nation’s fragmented patient portals. By establishing a single, standards‑based access point, patients would retrieve their...
Exploring TEFCA's Potential to Empower Rural Providers
University of Iowa Health Care’s AVP for information systems, Josh Wilda, highlighted that connecting to the Trusted Exchange Framework and Common Agreement (TEFCA) can enable rural Iowa clinics with limited IT resources to share patient data seamlessly. TEFCA’s standardized network...
Know Your Patient: How Technology Can Help Health Care Providers Dramatically Improve One Key Aspect of the Patient Experience
The article argues that AI can close the biggest gap in patient experience—feeling understood—by automating note summarization and turning wearable data into actionable insights. It notes that simple digitization of records has not reduced clinician workload, leaving patients frustrated and...
Wyss Institute’s Organ‑Chip Avatars Fly on Artemis II to Probe Astronaut Health
The Wyss Institute for Biologically Inspired Engineering and Emulate, Inc. have placed human bone‑marrow organ‑chip “avatars” on NASA’s Artemis II mission, launched April 1, 2026, to study how radiation and microgravity affect astronaut tissue. The experiment could reshape space‑medicine research and give...
Alan – Now Worth $7.8 Billion – Comes to Canada as It Accelerates Global Expansion
Digital health insurer Alan, now valued at $7.8 billion after a €100 million funding round, is accelerating its Canadian expansion. The company has secured nationwide licensing and is serving over 1,600 members from its Toronto office, with plans to open a Montreal...
Chinese Researchers Demonstrate CRISPR Cure for Β‑Thalassaemia in Clinical Trial
A consortium of Chinese scientists has shown that an enhanced CRISPR/Cas9 platform can safely correct the genetic defect behind β‑Thalassaemia in patients. The study builds on the recent FDA approval of a CRISPR therapy for sickle‑cell anemia and suggests a...
Lessons From HIMSS: AI Will Not Fix Healthcare: Informed Leadership Might
At HIMSS 2026, industry leaders acknowledged that AI is no longer a future possibility but a present reality in healthcare, with over 1,200 AI‑enabled medical devices already in use in the United States. However, the rapid pace of adoption has...
From Unused Data to Improved Experiences - How Trillium Health Partners Put Patient Voices to Work with Qualtrics
Trillium Health Partners in Mississauga replaced paper‑based patient surveys with Qualtrics’ digital platform, enabling feedback delivery within 24 hours of discharge. The real‑time insight allows unit managers to see complaints and compliments within days, turning stale data into actionable improvement. By...
The Healthcare Burnout Backlash (Pt 3): How Workflow Redesign Is Helping Healthcare Organizations Offset Staffing Shortages
The third installment of MedTech Intelligence’s burnout series argues that staffing shortages are symptoms of outdated, siloed workflows rather than pure labor deficits. Healthcare leaders are turning to targeted workflow redesign—especially in patient access, revenue cycle and EHR processes—to eliminate...
BD Announced Application of CE Mark for the Liverty TIPS Stent Graft
BD announced that its Liverty TIPS Stent Graft has received CE Mark approval, allowing sales across the European Union. The next‑generation device features an adjustable 6–10 mm inner diameter and the longest range of covered TIPS stent lengths, aimed at personalizing...
Endospan Receives FDA Approval for the NEXUS Aortic Arch Stent Graft System
Endospan announced FDA approval of its NEXUS Aortic Arch Stent Graft System, clearing the way for a U.S. commercial launch. The clearance was based on one‑year results from the TRIOMPHE IDE study, which demonstrated safe and effective treatment of high‑risk...
InVera Medical Receives FDA Clearance for Non-Thermal Chronic Venous Disease Device
InVera Medical secured FDA 510(k) clearance for its InVera Infusion Device, a 5Fr catheter with a helical coil designed to improve sclerotherapy delivery for chronic venous disease (CVD). The non‑thermal, minimally invasive tool prepares the vein wall mechanically, allowing a...
Ind. FD Launches Program to Divert Non-Emergency 911 Calls to Nurses
The Terre Haute Fire Department (THFD) has launched the Crosswalk to Care program to divert low‑acuity 911 calls to registered nurses for appropriate care navigation. Over the past seven years, THFD’s run calls grew by 450 annually, with roughly 20%—about...
Healthcare Business International Interviews Nelson Advisors Discussing Healthbridge's Acquisition of AI Scribe Nora
Healthbridge has acquired AI‑scribe startup Nora, marking a clear shift toward M&A rather than in‑house development in healthtech. The deal highlights soaring valuations for clinical AI tools, with revenue multiples now ranging from 9× to 14× and exit timelines compressing...
CNN Debuts Kara Swisher’s Six‑Part Docuseries on Extending Human Lifespan
CNN launched a six‑part documentary series titled “Kara Swisher Wants to Live Forever,” premiering Saturday, April 11, 2026. Hosted by veteran tech journalist Kara Swisher, the series probes the science, technology and commercial forces shaping human longevity. The debut places...
ArkBio Starts First‑Cohort Dosing of Long‑Acting Antiviral AK0406 in Australian Phase I Trial
Shanghai Ark Biopharmaceutical announced that the first cohort of healthy volunteers has been dosed in a Phase I trial of AK0406, its long‑acting antiviral drug‑Fc conjugate, in Australia. The trial will assess safety, tolerability and pharmacokinetics, and could pave the...
Meta’s Muse Spark AI Asks Users for Health Data, Prompting Privacy and Safety Alarm
Meta launched Muse Spark, an AI assistant that invites users to paste fitness‑tracker, glucose‑monitor or lab‑report numbers for analysis. Early testing revealed inaccurate medical guidance and raised alarms about data privacy, HIPAA compliance and potential misuse of health information.
Cleveland Clinic Catalyzer Program Awards $250K to Quantum Startups
Cleveland Clinic’s Quantum Innovation Catalyzer Program will award up to $250,000, matched with in‑kind resources, to three startups applying quantum computing to health challenges. The selected firms—EntangleBio, Polaris Quantum Biotech, and Singularity Quantum—gain access to IBM’s Quantum System One, the...
Surface‑Engineered Primer Immobilization Enables Simplified and Affordable Nucleic‑Acid Capture for Molecular Diagnostics in Sub‑Saharan Africa
A study introduces a silica‑free nucleic‑acid capture method using polycarbonate surfaces modified with acetone‑UV pretreatment and branched polyethyleneimine linkers. The treatment doubles surface carboxyl groups, and BPEI chemistry attaches about 2.6 times more primers than conventional ethylenediamine links. Fluorescence assays confirm...
Silex, Edge Impulse Team on Edge AI Development
Silex Technology and Edge Impulse have teamed up to integrate Edge Impulse’s end‑to‑end AI development platform with Silex’s EP‑200Q system‑on‑module, which runs on Qualcomm’s Dragonwing QCS6490 processor. The joint solution bundles a Wi‑Fi 7 driver and AI acceleration to simplify the...
New AI Femtech Competition in Portugal Aims to Fast-Track Women’s Health Innovation
Portugal is launching its first AI‑focused femtech competition, inviting both local and international teams to submit projects that apply imaging or time‑series data to women’s health challenges. The open call runs until 28 April 2026, with submissions due at midnight CET, and...
Telix Reports US FDA Acceptance of NDA for TLX101-Px (Pixclara) in Glioma Imaging
Telix Pharma announced that the U.S. FDA has accepted the resubmitted New Drug Application for TLX101‑Px, marketed as Pixclara, an investigational 18F‑FET PET imaging agent for glioma detection in adults and children. The agency set a PDUFA action date of...
South Korea to Fund Medical AI Device Rollout and More Briefs
South Korea's Ministry of Health and Welfare will allocate 8 billion won ($5.3 million) from the AX‑Sprint programme to fund commercialization of AI‑based medical devices, supporting consortia with hospitals for clinical validation and reimbursement between 2026‑27. Singapore's Nanyang Technological University launched the...
This Week in European MedTech and HealthTech: 10th April 2026
The European Commission released new guidance linking the AI Act to the MDR/IVDR, demanding higher data quality, risk management and human oversight for high‑risk AI medical software. The EU Health Technology Assessment framework is now fully operational, raising the evidence...
Iron‐Based Metal‐Organic Framework MIL‐100(Fe) Regulates Keloid Scarring in a Humanized Keloid Model
The study shows iron‑based metal‑organic framework MIL‑100(Fe) nanoparticles are highly biocompatible, rapidly taken up by keloid fibroblasts, and selectively inhibit the TGF‑β/SMAD pathway, reducing collagen I, collagen III, and P4HA1 expression. In vitro experiments maintained >90% cell viability and curtailed...
EBSCO Clinical Decisions Report: 80% of Clinicians Trust Evidence-Based AI Tools
EBSCO Clinical Decisions released a report showing a stark trust gap in AI‑driven clinical decision support. While 89% of clinicians believe AI‑CDS will improve outcomes, 64% of patients would rather see a doctor who does not use AI. Evidence‑based AI...
![[Perspectives] Mammography Should Include Artificial Intelligence Support](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/a8b50d033d7e546335a6ec09b92b1dc2.webp)
[Perspectives] Mammography Should Include Artificial Intelligence Support
The Mammography Screening with Artificial Intelligence (MASAI) randomised trial showed that a single radiologist assisted by an AI algorithm achieved higher sensitivity than the traditional double‑reading approach, while preserving specificity. Complementary studies from 2025‑2026 confirm AI’s scalability and equitable performance...
![[Correspondence] Contemporary Non-Invasive Imaging for Coronary Artery Disease](https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/e5f5d89f21057c303d0efa1bf29145af.webp)
[Correspondence] Contemporary Non-Invasive Imaging for Coronary Artery Disease
The correspondence highlights three critical clarifications to a recent review on non‑invasive cardiac imaging. First, it stresses that patients with non‑obstructive coronary arteries can still experience angina and ischemia due to microvascular dysfunction or vasospasm. Second, it reinterprets the role...
Imagene AI Partners with Daiichi Sankyo to Advance Multimodal Biomarker Discovery in Oncology
Imagene AI has teamed up with Daiichi Sankyo to use its OI Suite, powered by the CanvOI foundation model, for multimodal biomarker discovery in oncology. The collaboration will integrate H&E and IHC whole‑slide images with molecular and clinical data to...
Dermatologists Show Highest Melanoma Diagnostic Performance with AI Support
A systematic review of 11 prospective studies involving over 2,500 patients found that AI algorithms detect melanoma with sensitivity (80.9%) and specificity (75.6%) comparable to dermatologists (78.6% and 75.2%). When dermatologists used AI assistance, performance jumped to 91.9% sensitivity and...
IBM Win NHS App Deal
NHS England awarded IBM a two‑year contract worth £160.1 million (about $203 million) to advance the NHS App. The deal, running from May 1 2026 to March 31 2028, focuses on expanding features, AI‑driven triage, and user‑centred pathways. It marks a shift from IBM’s previous operational...
New EPR Goes Live in Torbay and South Devon
The Epic electronic patient record (EPR) system has gone live across Torbay and South Devon NHS Foundation Trust, linking hospital and community sites. The rollout initially connects Royal Devon University Healthcare and Torbay and South Devon Trust, with University Hospitals...
China's AI Hospital Makes Patients the Care Hub
China just defined what an AI Hospital is! It is a new type of smart healthcare model in which AI is embedded into the system itself, linking offline medical expertise with the broader reach of online services to deliver more...
Optical Genome Mapping Enhances AML Classification and Treatment
Optical genome mapping [OGM] improves the accuracy of classification, risk stratification, & personalized treatment strategies for Pts w/ acute myeloid leukemia [Jul 17, 2024] @sanamloghavi et al. @AjHematology https://t.co/R5ZLgolhuj #AMLsm #leusm #PrecisionMedicine #oncopath https://t.co/kX7KUJLK0L
South Korea Deploys Nationwide AI Platform to Manage Chronic Diseases
South Korea's Ministry of Health and Welfare rolled out the Medical AX initiative, a government‑backed AI platform that will oversee exercise, diet, primary care, imaging and remote consultations for chronic disease patients. The program, launched at a briefing in Seoul,...
AI Predicts Heart Failure Five Years Early via CT
AI to detect risk of heart failure 5 years ahead of symptoms via CT scan epicardial fat tissue https://t.co/RuZu8pSIAy @JACCJournals https://t.co/Gz052Ajj4X
Ultrasound Enables Non‑Invasive Control of Body Cells
"Sonogenics" is an emerging scientific field that uses ultrasound to non-invasively control and manipulate specific cells in the body, such as neurons or heart cells
Scala Biodesign Raises $16 Million Series A to Speed Protein Bio‑hacking
Scala Biodesign announced a $16 million Series A round led by Grove Ventures to expand its ScalaOS platform, which uses AI and physics‑based modeling to streamline protein engineering. The funding aims to cut years of trial‑and‑error for drugmakers developing longevity‑focused biologics.
AI Predicts Heart Failure up to Five Years Early
New #AI tool can predict heart failure at least five years before it develops https://t.co/PAVvWoOaAD
WHOOP AI Coach Shares Worthy Amb
Encouraged to see this perspective (articulated as an ambition-and I’d argue a very worthy one) from @WHOOP’s AI coach in response to question… @EmilyBreslow @willahmed https://t.co/YTdRL7pIgh
New Cancer Radiotherapy Machines Arrive at Mpilo Hospital
AT MPILO HOSPITAL, Old Radiotherapy Machines are being decommissioned & the newly procured machines are being installed. These are the “Cancer Machines” Zimbabweans have been talking about. President @edmnangagwa DELIVERED. ED2030🔥🔥🔥🔥 https://t.co/uoDZihr6L6
AI, Not Data Center Bans, Will Cure Cancer
If we are going to cure cancer in my lifetime, it’s going to be AI that does it. Think about that when you’re trying to ban data centers because they use less water than one crappy golf course
Advanced Biotech Delivers Precise Disease Detection
Accurate Disease Detection with Advanced Biotech Diagnostics by @antgrasso #MedTech #Healthcare #HealthTech #Tech #TechForGood https://t.co/71nTNGOdDQ